Shuchi Gulati

Title(s)Assistant Professor, MED: Int Med Hematology/Oncology
SchoolSchool of Medicine
AddressUC Davis Comprehensive Cancer Center
CA 95817
ORCID ORCID Icon0000-0001-6793-9694 Additional info
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. AI-Powered cellular morphometric biomarkers discovered in needle biopsy of prostatic cancer predict neoadjuvant androgen deprivation therapy response and prognosis: an international multicenter retrospective study. medRxiv. 2024 Nov 18. Yan H, Mao AW, Li D, Pérez-Baena MJ, Jiménez-Navas A, Wang D, Hong R, Cai W, Pérez-Losada J, Jen KY, Wang S, Peng S, Barcellos-Hoff MH, Mao JH, Fu Y, Iczkowski KA, Gulati S, Chang H. PMID: 39606414; PMCID: PMC11601692.
      View in: PubMed   Mentions:
    2. Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma. Cancer Discov. 2024 Oct 31. Bischoff ME, Shamsaei B, Yang J, Secic D, Vemuri B, Reisz JA, D'Alessandro A, Bartolacci C, Adamczak R, Schmidt L, Wang J, Martines A, Venkat J, Toffessi Tcheuyap V, Biesiada J, Behrmann CA, Vest KE, Brugarolas J, Scaglioni PP, Plas DR, Patra KC, Gulati S, Landero Figueroa JA, Meller J, Cunningham JT, Czyzyk-Krzeska MF. PMID: 39476412.
      View in: PubMed   Mentions: 1     Fields:    
    3. Differences in mutations across tumour sizes in clear-cell renal cell carcinoma. BJU Int. 2024 Sep 12. Monda SM, Carney BW, May AM, Gulati S, Salami SS, Chandrasekar T, Keller ET, Huebner NA, Palapattu GS, Dall'Era MA. PMID: 39263870.
      View in: PubMed   Mentions:    Fields:    
    4. Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. J Clin Oncol. 2024 Nov 20; 42(33):3911-3916. Barata P, Tangen C, Plets M, Thompson IM, Narayan V, George DJ, Heng DYC, Shuch B, Stein M, Gulati S, Tretiakova M, Tripathi A, Bjarnason GA, Humphrey P, Adeniran A, Vaishampayan U, Alva A, Zhang T, Cole S, Lara PN, Lerner SP, Balzer-Haas N, Pal SK. PMID: 39255440; PMCID: PMC11575905.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    5. Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic Review. Kidney Cancer. 2024; 8(1):115-123. Monda S, Lara PN, Gulati S. PMID: 39263257; PMCID: PMC11385085.
      View in: PubMed   Mentions:
    6. Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Aug 01; 7(8):e2425288. Gulati S, Tangen C, Ryan CW, Vaishampayan UN, Shuch BM, Barata PC, Pruthi DK, Bergerot CD, Tripathi A, Lerner SP, Thompson IM, Lara PN, Pal SK. PMID: 39106067; PMCID: PMC11304111.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    7. Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma. BJU Int. 2024 Oct; 134(4):596-601. Tripathi A, Tangen CM, Plets M, Li X, Tretiakova M, Humphrey PA, Adeniran A, Barata PC, Gulati S, Bergerot CD, Pruthi DK, Thompson IM, Lara PN, Lerner SP, Pal SK, Shuch BM. PMID: 39014969.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma. J Clin Invest. 2024 May 30; 134(14). Gulati S, Barata PC, Elliott A, Bilen MA, Burgess EF, Choueiri TK, Darabi S, Dawson NA, Gartrell BA, Hammers HJ, Heath EI, Magee D, Rao A, Ryan CJ, Twardowski P, Wei S, Brugarolas J, Zhang T, Zibelman MR, Nabhan C, McKay RR. PMID: 39007269; PMCID: PMC11245151.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    9. Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial. Eur Urol. 2024 Sep; 86(3):258-264. Lara PN, Tangen C, Heath EI, Gulati S, Stein MN, Meng M, Alva AS, Pal SK, Puzanov I, Clark JI, Choueiri TK, Agarwal N, Uzzo R, Haas NB, Synold TW, Plets M, Vaishampayan UN, Shuch BM, Lerner S, Thompson IM, Ryan CW. PMID: 38811313.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    10. Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles. J Clin Invest. 2024 Apr 23; 134(11). Barata P, Gulati S, Elliott A, Hammers HJ, Burgess E, Gartrell BA, Darabi S, Bilen MA, Basu A, Geynisman DM, Dawson NA, Zibelman MR, Zhang T, Wei S, Ryan CJ, Heath EI, Poorman KA, Nabhan C, McKay RR. PMID: 38652565; PMCID: PMC11142736.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    11. Belzutifan versus Everolimus in Advanced Kidney Cancer: A Commentary on LITESPARK-005 Trial from ESMO 2023. Kidney Cancer. 2024; 8(1):23-24. Gulati S, Lara PN. PMID: 38420616; PMCID: PMC10897857.
      View in: PubMed   Mentions: 2  
    12. Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma. bioRxiv. 2024 Jan 19. Bischoff ME, Shamsaei B, Yang J, Secic D, Vemuri B, Reisz JA, D'Alessandro A, Bartolacci C, Adamczak R, Schmidt L, Wang J, Martines A, Biesiada J, Vest KE, Scaglioni PP, Plas DR, Patra KC, Gulati S, Figueroa JAL, Meller J, Cunningham JT, Czyzyk-Krzeska MF. PMID: 38293110; PMCID: PMC10827129.
      View in: PubMed   Mentions:
    13. Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC). Clin Genitourin Cancer. 2024 04; 22(2):217-223. Mar N, Dwabe S, Baranda MN, Zarrabi KK, Eturi A, Gulati S, Parikh M, Seyedin SN, Kalebasty AR. PMID: 38087703.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol. 2023 10 01; 9(10):1390-1400. Gulati S, Hsu CY, Shah S, Shah PK, Zon R, Alsamarai S, Awosika J, El-Bakouny Z, Bashir B, Beeghly A, Berg S, de-la-Rosa-Martinez D, Doroshow DB, Egan PC, Fein J, Flora DB, Friese CR, Fromowitz A, Griffiths EA, Hwang C, Jani C, Joshi M, Khan H, Klein EJ, Heater NK, Koshkin VS, Kwon DH, Labaki C, Latif T, McKay RR, Nagaraj G, Nakasone ES, Nonato T, Polimera HV, Puc M, Razavi P, Ruiz-Garcia E, Saliby RM, Shastri A, Singh SRK, Tagalakis V, Vilar-Compte D, Weissmann LB, Wilkins CR, Wise-Draper TM, Wotman MT, Yoon JJ, Mishra S, Grivas P, Shyr Y, Warner JL, Connors JM, Shah DP, Rosovsky RP, COVID-19 and Cancer Consortium. PMID: 37589970; PMCID: PMC10436185.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    15. Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial. Clin Cancer Res. 2023 05 15; 29(10):1906-1915. Gulati S, Crist M, Riaz MK, Takiar V, Lehn M, Monroe I, Palackdharry S, Kurtzweil N, Jandarov R, Harun N, Wise-Draper TM. PMID: 36802410; PMCID: PMC10192200.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    16. A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma. Eur Urol Oncol. 2023 06; 6(3):339-348. McGregor B, Geynisman DM, Burotto M, Suárez C, Bourlon MT, Barata PC, Gulati S, Huo S, Ejzykowicz F, Blum SI, Del Tejo V, Hamilton M, May JR, Du EX, Wu A, Kral P, Ivanescu C, Chin A, Betts KA, Lee CH, Choueiri TK, Cella D, Porta C. PMID: 36842942.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19. JAMA Oncol. 2023 01 01; 9(1):128-134. Bakouny Z, Labaki C, Grover P, Awosika J, Gulati S, Hsu CY, Alimohamed SI, Bashir B, Berg S, Bilen MA, Bowles D, Castellano C, Desai A, Elkrief A, Eton OE, Fecher LA, Flora D, Galsky MD, Gatti-Mays ME, Gesenhues A, Glover MJ, Gopalakrishnan D, Gupta S, Halfdanarson TR, Hayes-Lattin B, Hendawi M, Hsu E, Hwang C, Jandarov R, Jani C, Johnson DB, Joshi M, Khan H, Khan SA, Knox N, Koshkin VS, Kulkarni AA, Kwon DH, Matar S, McKay RR, Mishra S, Moria FA, Nizam A, Nock NL, Nonato TK, Panasci J, Pomerantz L, Portuguese AJ, Provenzano D, Puc M, Rao YJ, Rhodes TD, Riely GJ, Ripp JJ, Rivera AV, Ruiz-Garcia E, Schmidt AL, Schoenfeld AJ, Schwartz GK, Shah SA, Shaya J, Subbiah S, Tachiki LM, Tucker MD, Valdez-Reyes M, Weissmann LB, Wotman MT, Wulff-Burchfield EM, Xie Z, Yang YJ, Thompson MA, Shah DP, Warner JL, Shyr Y, Choueiri TK, Wise-Draper TM, COVID-19 and Cancer Consortium. PMID: 36326731; PMCID: PMC9634600.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    18. Immune Checkpoint Inhibitors in the Pre-operative Setting and Impact on the Primary Renal Tumor. Kidney Cancer. 2022; 6(4):201-203. Gulati S, Lara PN. PMID: 36726555; PMCID: PMC9837794.
      View in: PubMed   Mentions: 1  
    19. Anticoagulant Therapy for Cancer-Associated Thrombosis : A Cost-Effectiveness Analysis. Ann Intern Med. 2023 01; 176(1):1-9. Gulati S, Eckman MH. PMID: 36571839; PMCID: PMC10279520.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    20. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition. J Immunother Cancer. 2022 11; 10(11). Crist M, Yaniv B, Palackdharry S, Lehn MA, Medvedovic M, Stone T, Gulati S, Karivedu V, Borchers M, Fuhrman B, Crago A, Curry J, Martinez-Outschoorn U, Takiar V, Wise-Draper TM. PMID: 36328378; PMCID: PMC9639146.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    21. Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res. 2022 08 15; 28(16):3464-3472. Leddon JL, Gulati S, Haque S, Allen C, Palackdharry S, Mathews M, Kurtzweil N, Riaz MK, Takiar V, Nagasaka M, Patil Y, Zender C, Tang A, Cervenka B, McGrath J, Korn WM, Hinrichs BH, Jandarov R, Harun N, Sukari A, Wise-Draper TM. PMID: 35653116; PMCID: PMC9378458.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    22. Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2022 04 01; 28(7):1345-1352. Wise-Draper TM, Gulati S, Palackdharry S, Hinrichs BH, Worden FP, Old MO, Dunlap NE, Kaczmar JM, Patil Y, Riaz MK, Tang A, Mark J, Zender C, Gillenwater AM, Bell D, Kurtzweil N, Mathews M, Allen CL, Mierzwa ML, Casper K, Jandarov R, Medvedovic M, Lee JJ, Harun N, Takiar V, Gillison M. PMID: 35338369; PMCID: PMC8976828.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    23. First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape. Oncologist. 2022 03 04; 27(2):125-134. Gulati S, Labaki C, Karachaliou GS, Choueiri TK, Zhang T. PMID: 35641205; PMCID: PMC8895741.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    24. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study. Open Forum Infect Dis. 2022 Mar; 9(3):ofac037. Satyanarayana G, Enriquez KT, Sun T, Klein EJ, Abidi M, Advani SM, Awosika J, Bakouny Z, Bashir B, Berg S, Bernardes M, Egan PC, Elkrief A, Feldman LE, Friese CR, Goel S, Gomez CG, Grant KL, Griffiths EA, Gulati S, Gupta S, Hwang C, Jain J, Jani C, Kaltsas A, Kasi A, Khan H, Knox N, Koshkin VS, Kwon DH, Labaki C, Lyman GH, McKay RR, McNair C, Nagaraj G, Nakasone ES, Nguyen R, Nonato TK, Olszewski AJ, Panagiotou OA, Puc M, Razavi P, Robilotti EV, Santos-Dutra M, Schmidt AL, Shah DP, Shah SA, Vieira K, Weissmann LB, Wise-Draper TM, Wu U, Wu JT, Choueiri TK, Mishra S, Warner JL, French B, Farmakiotis D. PMID: 35198648; PMCID: PMC8860152.
      View in: PubMed   Mentions: 4  
    25. Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium. Lancet Healthy Longev. 2022 03; 3(3):e143-e152. Elkrief A, Hennessy C, Kuderer NM, Rubinstein SM, Wulff-Burchfield E, Rosovsky RP, Vega-Luna K, Thompson MA, Panagiotou OA, Desai A, Rivera DR, Khaki AR, Tachiki L, Lynch RC, Stratton C, Elias R, Batist G, Kasi A, Shah DP, Bakouny Z, Cabal A, Clement J, Crowell J, Dixon B, Friese CR, Fry SL, Grover P, Gulati S, Gupta S, Hwang C, Khan H, Kim SJ, Klein EJ, Labaki C, McKay RR, Nizam A, Pennell NA, Puc M, Schmidt AL, Shahrokni A, Shaya JA, Su CT, Wall S, Williams N, Wise-Draper TM, Mishra S, Grivas P, French B, Warner JL, Wildes TM, COVID-19 and Cancer Consortium. PMID: 35187516; PMCID: PMC8843069.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    26. Spectrum of Presentations and Management Strategies in Renal Angiomyolipoma. J Kidney Cancer VHL. 2022; 9(1):42-47. Khaddam S, Gulati S. PMID: 35127338; PMCID: PMC8808295.
      View in: PubMed   Mentions: 3  
    27. Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer. Front Oncol. 2021; 11:786216. Luginbuhl A, Calder A, Kutler D, Zender C, Wise-Draper T, Patel J, Cheng M, Karivedu V, Zhan T, Parashar B, Gulati S, Yao M, Lavertu P, Takiar V, Tang A, Johnson J, Keane W, Curry J, Cognetti D, Bar-Ad V. PMID: 34900741; PMCID: PMC8660666.
      View in: PubMed   Mentions: 6  
    28. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19. JAMA Netw Open. 2021 11 01; 4(11):e2134330. Schmidt AL, Tucker MD, Bakouny Z, Labaki C, Hsu CY, Shyr Y, Armstrong AJ, Beer TM, Bijjula RR, Bilen MA, Connell CF, Dawsey SJ, Faller B, Gao X, Gartrell BA, Gill D, Gulati S, Halabi S, Hwang C, Joshi M, Khaki AR, Menon H, Morris MJ, Puc M, Russell KB, Shah NJ, Sharifi N, Shaya J, Schweizer MT, Steinharter J, Wulff-Burchfield EM, Xu W, Zhu J, Mishra S, Grivas P, Rini BI, Warner JL, Zhang T, Choueiri TK, Gupta S, McKay RR. PMID: 34767021; PMCID: PMC8590166.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    29. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. J Thromb Haemost. 2021 10; 19(10):2522-2532. Li A, Kuderer NM, Hsu CY, Shyr Y, Warner JL, Shah DP, Kumar V, Shah S, Kulkarni AA, Fu J, Gulati S, Zon RL, Li M, Desai A, Egan PC, Bakouny Z, Kc D, Hwang C, Akpan IJ, McKay RR, Girard J, Schmidt AL, Halmos B, Thompson MA, Patel JM, Pennell NA, Peters S, Elshoury A, de Lima Lopes G, Stover DG, Grivas P, Rini BI, Painter CA, Mishra S, Connors JM, Lyman GH, Rosovsky RP, CCC19 consortium. PMID: 34260813; PMCID: PMC8420489.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    30. Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. Int J Cancer. 2021 10 01; 149(7):1455-1462. Yekedüz E, Trapani D, Xu W, de Vries EGE, Labaki C, Gyawali B, Gulati S, Nabhan C, Utkan G, Curigliano G, Choueiri TK, Ürün Y. PMID: 34124786.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. Biomarkers in renal cell carcinoma: Are we there yet? Asian J Urol. 2021 Oct; 8(4):362-375. Gulati S, Vogelzang NJ. PMID: 34765444; PMCID: PMC8566366.
      View in: PubMed   Mentions: 12  
    32. Highlights from the American society of hematology conference 2020. J Thromb Thrombolysis. 2021 Jul; 52(1):354-362. Grover P, Gulati S. PMID: 33900522; PMCID: PMC8072747.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    33. Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma. Genes (Basel). 2021 03 09; 12(3). Czyzyk-Krzeska MF, Landero Figueroa JA, Gulati S, Cunningham JT, Meller J, ShamsaeI B, Vemuri B, Plas DR. PMID: 33803184; PMCID: PMC7999481.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    34. Systemic therapy and COVID19: Immunotherapy and chemotherapy. Urol Oncol. 2021 04; 39(4):213-220. Gulati S, Muddasani R, Gustavo Bergerot P, Pal SK. PMID: 33451934; PMCID: PMC7762713.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    35. COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspective. Cancer Med. 2020 09; 9(17):6141-6146. Marcum M, Kurtzweil N, Vollmer C, Schmid L, Vollmer A, Kastl A, Acker K, Gulati S, Grover P, Herzog TJ, Ahmad SA, Sohal D, Wise-Draper TM. PMID: 32648667; PMCID: PMC7404529.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    36. Evolving treatment paradigm in metastatic non clear cell renal cell carcinoma. Cancer Treat Res Commun. 2020 Mar 17; 23:100172. Gulati S, Philip E, Salgia S, Pal SK. PMID: 32252014.
      View in: PubMed   Mentions: 7     Fields:    
    37. Current State of Systemic Therapies for Advanced Renal Cell Carcinoma. Curr Oncol Rep. 2020 02 11; 22(3):26. Gulati S, Vaishampayan U. PMID: 32048058.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    38. Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience. J Int Med Res. 2019 Dec; 47(12):6016-6026. Abdel Karim NF, Hassan R, Siddiqi NI, Eldessouki I, Gaber O, Rahouma M, Kamel M, Yellu M, Gulati S, Xie C, Magdy M, Pruemer J. PMID: 31640444; PMCID: PMC7045662.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer. Cancer. 2020 01 15; 126(2):354-362. Gulati S, Desai J, Palackdharry SM, Morris JC, Zhu Z, Jandarov R, Riaz MK, Takiar V, Mierzwa M, Gutkind JS, Molinolo A, Desai PB, Sadraei NH, Wise-Draper TM. PMID: 31626727; PMCID: PMC10402880.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    40. Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States. J Gastrointest Oncol. 2016 Dec; 7(6):996-1003. Agarwal R, Sendilnathan A, Siddiqi NI, Gulati S, Ghose A, Xie C, Olowokure OO. PMID: 28078124; PMCID: PMC5177586.
      View in: PubMed   Mentions: 13  
    41. Ocular Adnexal Lymphoma Presenting with Visual Loss. N Am J Med Sci. 2016 Jan; 8(1):56-60. Gulati S, Corrêa ZM, Karim N, Medlin S. PMID: 27011948; PMCID: PMC4784184.
      View in: PubMed   Mentions:
    42. Order of curricular interventions in recognition of haematopathological images. Med Educ. 2015 Nov; 49(11):1140-1. Gulati S, Wasser T, Donato AA. PMID: 26494068.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Diabetes Insipidus: An Unusual Presentation of Adenocarcinoma of the Lung in a Patient with no Identifiable Lung Mass. N Am J Med Sci. 2015 Oct; 7(10):476-9. Gulati S, Kiefer C, Karim NA. PMID: 26713294; PMCID: PMC4677473.
      View in: PubMed   Mentions: 2  
    44. Surprising cause of dysphagia in an elderly male. J Community Hosp Intern Med Perspect. 2014; 4(4). Bennett K, Supplee S, Vyas P, Gulati S, Alweis R. PMID: 25317263; PMCID: PMC4185141.
      View in: PubMed   Mentions: 1  
    45. Vasculitides associated with haematological malignancies: a case-based review. BMJ Case Rep. 2012 Oct 19; 2012. Gulati S, Patel NP, Swierczynski SL. PMID: 23087285; PMCID: PMC4544282.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis. 2012 Jul; 34(1):7-10. Gulati S, Donato AA. PMID: 22437653.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    47. Lynch Syndrome Associated With PMS2 Mutation: Understanding Current Concepts. Gastrointest Cancer Res. 2011 Sep; 4(5-6):188-90. Gulati S, Gustafson S, Daw HA. PMID: 22295133; PMCID: PMC3269140.
      View in: PubMed   Mentions: 2  
    Shuchi's Networks
    Concepts (132)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (16)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-8-gc1ed69da on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California